Moreover, EZN‐2208 inhibited HIF2α and not HIF1α, as measured by expression of HIFα factors and their regulated genes in AML cells recovered from treated mice (Fig EV4G). The gene discussed is EPAS1; the disease is acute myeloid leukemia.